We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Immune Response Pathway That Leads to Severe COVID-19 Identified
News

Immune Response Pathway That Leads to Severe COVID-19 Identified

Immune Response Pathway That Leads to Severe COVID-19 Identified
News

Immune Response Pathway That Leads to Severe COVID-19 Identified

Credit: Gerd Altmann/ Pixabay
Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Immune Response Pathway That Leads to Severe COVID-19 Identified"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Yale researchers have identified a particular immune response pathway that leads to severe illness and death in people infected by the SARS-CoV-2 virus.


The study was published April 28 in the journal Nature.


Researchers have known that once the COVID-19 virus infects the lungs it can trigger what has been called a “cytokine storm,” or an overactive immune response that leads to deadly inflammation in the lungs. For the new study, a Yale team led by postdoctoral fellow Esen Sefik, who is part of the lab of senior author Richard Flavell, studied the effects of SARS-CoV-2 infection in mice engineered to have a human immune system.


To their surprise, they found that immune cells themselves, not just epithelial cells lining the lung, can harbor the virus. When the body detects the virus in these cells, inflammasomes, part of the immune system’s early warning system, produce and release cytokines which prompt these immune cells to commit suicide in an attempt to abort infection. However, the cytokines also recruit even more inflammatory cells to the lungs from the blood, which drives a vicious cycle that leads to pneumonia.


It’s like a broadcast system, but in this case the message is lethal,” said Flavell, Sterling Professor of Immunobiology and investigator for the Howard Hughes Medical Institute.


In the mouse model of COVID-19, researchers were able to rescue infected mice from pneumonia by blocking the NLPR3 inflammasome pathway. With the inflammasome pathway blocked, immune system cells were still infected. But they were no longer inflammatory and therefore could not contribute to damaging levels of inflammation, researchers found.


One byproduct of this rescue, however, is that the cells no longer die and as a consequence release more virus. Nonetheless, blockade of the inflammasome pathway along with antiviral treatment could provide a way to treat COVID-19 pneumonia and prevent severe cases of COVID -19, researchers say.


Although there are no approved drugs that block the NLPR3 pathway, several pharmaceutical and biotech companies are developing them, Flavell said.


The research was funded by the Howard Hughes Medical Institute.


Reference: Sefik E, Qu R, Junqueira C, et al. Inflammasome activation in infected macrophages drives COVID-19 pathology. Nature. 2022. doi: 10.1038/s41586-022-04802-1 

 

This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.

Advertisement